Literature DB >> 26527169

Review article: insights into colonic protein fermentation, its modulation and potential health implications.

C K Yao1, J G Muir1, P R Gibson1.   

Abstract

BACKGROUND: Beneficial effects of carbohydrate fermentation on gastrointestinal health are well established. Conversely, protein fermentation generates harmful metabolites but their relevance to gastrointestinal health is poorly understood. AIM: To review the effects of increased protein fermentation on biomarkers of colonic health, factors influencing fermentative activity and potential for dietary modulation to minimise detrimental effects.
METHODS: A literature search was performed in PubMed, Medline, EMBASE and Google scholar for clinical and pre-clinical studies using search terms - 'dietary protein', 'fermentation', 'putrefaction', 'phenols', 'sulphide', 'branched-chain fatty acid', 'carbohydrate fermentation', 'gastrointestinal'.
RESULTS: High protein, reduced carbohydrate diets alter the colonic microbiome, favouring a potentially pathogenic and pro-inflammatory microbiota profile, decreased short-chain fatty acid production and increased ammonia, phenols and hydrogen sulphide concentrations. These metabolites largely compromise the colonic epithelium structure, causing mucosal inflammation but may also directly modulate the enteric nervous system and intestinal motility. Increased protein fermentation as a result of a high-protein intake can be attenuated by addition of oligosaccharides, resistant starch and nonstarch polysaccharides and a reduction in total protein or specifically, aromatic and sulphur-containing amino acids. These factors may have clinical importance as novel therapeutic approaches to problems, in which protein fermentation may be implicated, such as malodorous flatus, irritable bowel syndrome, ulcerative colitis and prevention of colorectal cancer.
CONCLUSIONS: The direct clinical relevance of excessive protein fermentation in the pathogenesis of irritable bowel syndrome, malodorous flatus and ulcerative colitis are underexplored. Manipulating dietary carbohydrate and protein intake have potential therapeutic applications in such settings and warrant further clinical studies.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527169     DOI: 10.1111/apt.13456

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  97 in total

Review 1.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

2.  Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.

Authors:  Jørgen Valeur; Milada Cvancarova Småstuen; Torunn Knudsen; Gülen Arslan Lied; Arne Gustav Røseth
Journal:  Dig Dis Sci       Date:  2018-01-04       Impact factor: 3.199

3.  Maternal obesity is associated with gut microbial metabolic potential in offspring during infancy.

Authors:  Tomás Cerdó; Alicia Ruiz; Ruy Jáuregui; Hatim Azaryah; Francisco José Torres-Espínola; Luz García-Valdés; M Teresa Segura; Antonio Suárez; Cristina Campoy
Journal:  J Physiol Biochem       Date:  2017-08-17       Impact factor: 4.158

4.  Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  SeonYoon Chung; Jennifer L Barnes; Kim Schafer Astroth
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

Review 5.  Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.

Authors:  Zeinab Mokhtari; Deanna L Gibson; Azita Hekmatdoost
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

6.  Modulation of colonic hydrogen sulfide production by diet and mesalazine utilizing a novel gas-profiling technology.

Authors:  Chu K Yao; Asaf Rotbart; Jian Z Ou; Kourosh Kalantar-Zadeh; Jane G Muir; Peter R Gibson
Journal:  Gut Microbes       Date:  2018-05-09

7.  Dietary Proteins Alter Fermentation Characteristics of Human Gut Microbiota In Vitro.

Authors:  Tianzhen Xiao; Tingting Liang; Dong-Hui Geng; Lili Wang; Liya Liu; Xianrong Zhou; Huayin Pu; Junrong Huang; Sumei Zhou; Li-Tao Tong
Journal:  Plant Foods Hum Nutr       Date:  2021-12       Impact factor: 3.921

Review 8.  Gut microbial metabolites in obesity, NAFLD and T2DM.

Authors:  Emanuel E Canfora; Ruth C R Meex; Koen Venema; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 9.  Fueling Gut Microbes: A Review of the Interaction between Diet, Exercise, and the Gut Microbiota in Athletes.

Authors:  Riley L Hughes; Hannah D Holscher
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

10.  Effects of continuously infusing glucose or casein into the terminal ileum on biomarkers of metabolism, inflammation, and intestinal morphology in growing pigs.

Authors:  Edith J Mayorga; Erin A Horst; Mohmmad Al-Qaisi; Brady M Goetz; Megan A Abeyta; Sonia Rodríguez-Jiménez; Samantha Lei; Jesus A Acosta; John F Patience; Mariana C Rossoni Serao; Lance H Baumgard
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.